Jian Zhang

Title: Innovations in Cancer Treatment by Inventor Jian Zhang

Introduction

Jian Zhang is a prominent inventor based in Ann Arbor, MI (US), known for his significant contributions to cancer treatment through innovative compounds and methods. With a total of 2 patents, his work focuses on sensitizing cancer cells to various therapeutic agents, thereby enhancing the effectiveness of cancer treatments.

Latest Patents

One of Jian Zhang's latest patents is titled "Compounds and methods to sensitize cancer cells to cisplatin." This invention relates to sensitizer compounds that enhance the sensitivity of cancer and pre-cancerous cells to cisplatin, a commonly used chemotherapy drug. The patent describes the use of conjugates of specific esters or amides of Near Infrared Dyes as sensitizers to overcome therapeutic resistance. The invention is particularly beneficial for cancers that tend to develop resistance to treatments, including lung, pancreatic, and breast cancers.

Another notable patent by Jian Zhang is "Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitors." This invention focuses on sensitizer compounds used in combination with Tyrosine Kinase Inhibitors (TKIs) to improve treatment outcomes for tumors and cancers that exhibit TKI resistance. The patent outlines administration regimes that combine TKIs with TKI-sensitizing compounds, enhancing the efficacy of treatments for cancers such as lung and pancreatic cancer.

Career Highlights

Throughout his career, Jian Zhang has worked with notable organizations, including Da Zen Theranostics, Inc. and Cedars-Sinai Medical Center. His experience in these institutions has contributed to his expertise in cancer research and treatment innovations.

Collaborations

Jian Zhang has collaborated with esteemed colleagues, including Liyuan Yin and Yi Zhang, to advance research in cancer therapies. Their combined efforts have led to significant developments in the field.

Conclusion

Jian Zhang's innovative work in cancer treatment through his patents demonstrates his commitment to improving therapeutic outcomes for patients. His contributions to sensitizing cancer cells to various treatments highlight the potential for enhanced efficacy in combating resistant cancers.